logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Toshihiko Matsumoto

ichinomiya nishi hospital
H指数:10
被引数:621

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab

紫杉类药物联合ramucirumab治疗化疗联合nivolumab后进展的晚期胃癌的疗效与安全性

Scientific Reports
IF3.9
2025-08-070
OA
Toshihiko Matsumoto; Tatsuki Ikoma; Chinatsu Makiyama; Tomoyo Yasuda; Shogen Boku; Akio Nakasya; Nobuhiro Shibata; Hiroki Nagai; Takao Tsuduki; Yusuke Matsumoto; Hisateru Yasui; Reiji Higashi; Akitoshi Sasamoto; Hironaga Satake; Kentaro Inoue; Masashi Kanai; Makoto Yamasaki
A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G

一项多中心II期研究，评估mFOLFOX6联合nivolumab治疗伴有严重腹膜转移的胃癌：WJOG16322G

Future Oncology
IF2.6
2025-06-060
OA
Munehiro Wakabayashi; Toshiki Masuishi; Takatsugu Ogata; Fumiyasu Hanamura; Mitsuhiro Furuta; Yoshiyuki Yamamoto; Kentaro Kawakami; Hidekazu Hirano; Yosuke Kito; Naoki Izawa; Naoki Takahashi; Toshihiko Matsumoto; Hisato Kawakami; Takayuki Ando; Keiko Minashi; Chiho Kudo; Kenichi Yoshimura; Kei Muro
The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma

FOLFOX治疗晚期食管鳞癌的疗效和安全性

SCIENTIFIC REPORTS
IF3.9
2025-03-070
OAAI
Shiraishi, Kazuhiro; Okada, Mao; Yamamoto, Shun; Matsubara, Yuki; Masuishi, Toshiki; Shimozaki, Keitaro; Yamamoto, Yoshiyuki; Hirose, Suguru; Sugiyama, Keiji; Furuta, Mitsuhiro; Machida, Nozomu; Takahashi, Naoki; Yoshii, Takako; Kito, Yosuke; Tsuzuki, Takao; Boku, Shogen; Tsuchihashi, Kenji; Sugaya, Akinori; Takayama, Toshizo; Komori, Azusa; Mitani, Seiichiro; Matsumoto, Toshihiko; Nishimura, Takashi; Hirata, Kenro
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS

WJOG13320GPS: 微卫星不稳定性高转移性或复发性胃癌和食管胃结合部癌的患病率和临床病理特征

GASTRIC CANCER
IF5.1
2024-12-310
PRE
Komori, Azusa; Hironaka, Shuichi; Kadowaki, Shigenori; Mitani, Seiichiro; Furuta, Mitsuhiro; Kawakami, Takeshi; Makiyama, Akitaka; Takegawa, Naoki; Sugiyama, Keiji; Hirano, Hidekazu; Ando, Takayuki; Matsushima, Tomohiro; Chida, Akihiko; Kashiwada, Tomomi; Komoda, Masato; Matsumoto, Toshihiko; Oda, Hisanobu; Yabusaki, Hiroshi; Kawakami, Hisato; Yamazaki, Kentaro; Boku, Narikazu; Hyodo, Ichinosuke; Yoshimura, Kenichi; Muro, Kei
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G
TARGETED ONCOLOGY
IF4
2024-03-010
OAAI
Matsumoto, Toshihiko; Yamamoto, Yoshiyuki; Kotaka, Masahito; Masuishi, Toshiki; Tsuji, Yasushi; Shoji, Hirokazu; Hirata, Kenro; Tsuduki, Takao; Makiyama, Akitaka; Izawa, Naoki; Takahashi, Naoki; Tsuda, Masahiro; Yasui, Hisateru; Ohta, Takashi; Kito, Yosuke; Otsu, Satoshi; Hironaka, Shuichi; Yamazaki, Kentaro; Boku, Narikazu; Hyodo, Ichinosuke; Yoshimura, Kenichi; Muro, Kei
Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study

转移性结直肠癌易感患者的真实世界治疗测序: 一项多中心回顾性研究

TARGETED ONCOLOGY
IF4
2023-09-052
PRE
Mitani, Seiichiro; Kito, Yosuke; Hino, Kaori; Kawakami, Kentaro; Izawa, Naoki; Hanamura, Fumiyasu; Yamamoto, Yoshiyuki; Shoji, Hirokazu; Komori, Azusa; Boku, Shogen; Tsuchihashi, Kenji; Kato, Kyoko; Nonagase, Yoshikane; Matsumoto, Toshihiko; Furuta, Mitsuhiro; Kawakami, Hisato
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G)

氟尿苷/替匹拉西 (FTD/TPI) 联合雷莫昔单抗 (RAM) 与氟尿苷/替匹拉西单抗治疗先前治疗的晚期胃或食管胃交界处腺癌患者的随机II期试验 (检索研究，WJOG15822G)

BMC CANCER
IF3.4
2023-08-054
OAAI
Takahashi, Naoki; Hara, Hiroki; Nagashima, Kengo; Hirata, Kenro; Masuishi, Toshiki; Matsumoto, Toshihiko; Kawakami, Hisato; Yamazaki, Kentaro; Hironaka, Shuichi; Boku, Narikazu; Muro, Kei
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial

在先前抗EGFR抗体难以治疗的RAS野生型mCRC患者中，三氟尿苷/替匹拉西联合西妥昔单抗再激发的II期试验: WJOG8916G试验

TARGETED ONCOLOGY
IF4
2023-05-064
PRE
Izawa, Naoki; Masuishi, Toshiki; Takahashi, Naoki; Shoji, Hirokazu; Yamamoto, Yoshiyuki; Matsumoto, Toshihiko; Sugiyama, Keiji; Kajiwara, Takeshi; Kawakami, Kentaro; Aomatsu, Naoki; Kondoh, Chihiro; Kawakami, Hisato; Takegawa, Naoki; Esaki, Taito; Shimokawa, Mototsugu; Nishio, Kazuto; Narita, Yukiya; Hara, Hiroki; Sunakawa, Yu; Boku, Narikazu; Moriwaki, Toshikazu; Nakajima, Takako Eguchi; Muro, Kei
TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer
FUTURE ONCOLOGY
IF2.6
2022-12-082
OA
Boku, Shogen; Satake, Hironaga; Ohta, Takashi; Mitani, Seiichiro; Kawakami, Kentaro; Suzuki, Yozo; Matsumoto, Toshihiko; Terazawa, Tetsuji; Yamazaki, Eiki; Hasegawa, Hiroko; Ikoma, Tatsuki; Uemura, Mamoru; Yamaguchi, Toshifumi; Naito, Atsushi; Ishizuka, Yasunobu; Kurokawa, Yukinori; Sakai, Daisuke; Kawakami, Hisato; Shimokawa, Toshio; Tsujinaka, Toshimasa; Kato, Takeshi; Satoh, Taroh; Kagawa, Yoshinori
WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAFV600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)

WJOG13219G: FOLFOXIRI或Doublet联合抗VEGF治疗先前未治疗的BRAFV600E突变转移性结直肠癌的疗效和安全性: 一项基于多机构注册研究 (手镯研究)

CLINICAL COLORECTAL CANCER
IF3.2
2022-12-013
PRE
Shimozaki, Keitaro; Hirata, Kenro; Sato, Taro; Nakamura, Maho; Kato, Kyoko; Hirano, Hidekazu; Kumekawa, Yosuke; Hino, Kaori; Kawakami, Kentaro; Kito, Yosuke; Matsumoto, Toshihiko; Kawakami, Takeshi; Komoda, Masato; Nagashima, Kengo; Sato, Yasunori; Yamazaki, Kentaro; Hironaka, Shuichi; Takaishi, Hiromasa; Hamamoro, Yasuo; Muro, Kei
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan

与晚期胃癌预后不良相关的nivolumab三线或晚期化疗期间的疾病进展模式: 日本的一项多中心回顾性研究

GASTRIC CANCER
IF5.1
2022-11-016
OAAI
Aoki, Masahiko; Kadowaki, Shigenori; Takahashi, Naoki; Suzuki, Takeshi; Oshima, Kotoe; Ando, Takayuki; Yamamoto, Yoshiyuki; Kawakami, Kentaro; Kito, Yosuke; Matsumoto, Toshihiko; Shimozaki, Keitaro; Miyazaki, Yasuhiro; Yamaguchi, Toshifumi; Nagase, Michitaka; Tamura, Takao; Amanuma, Yusuke; Esaki, Taito; Miura, Yuji; Akiyoshi, Kohei; Baba, Eishi; Makiyama, Akitaka; Negoro, Yuji; Nakashima, Koji; Sugimoto, Naotoshi; Nagashima, Kengo; Shoji, Hirokazu; Boku, Narikazu

研究方向

暂未获取到该数据
H
Hisateru Yasui
H 指数:25论文数:285被引数:5,540
T
Tatsuki Ikoma
H 指数:5论文数:88被引数:121
S
Shogen Boku
H 指数:10论文数:129被引数:450
H
Hiroki Nagai
H 指数:21论文数:126被引数:2,170
H
Hisato Kawakami
H 指数:43论文数:446被引数:8,777
K
Kentaro Kawakami
H 指数:10论文数:78被引数:752
M
Masahiro Takatani
H 指数:10论文数:80被引数:526
N
Naoki Takahashi
H 指数:23论文数:223被引数:2,923
H
Hironaga Satake
H 指数:24论文数:314被引数:3,551
Y
Yoshiyuki Yamamoto
H 指数:24论文数:263被引数:3,421